Division of Surgery, Kyoto Prefectural Yosanoumi Hospital, 481 Otokoyama, Yosano-cho, Yosa-gun, Kyoto 629-2261, Japan.
World J Surg Oncol. 2012 Jan 25;10:22. doi: 10.1186/1477-7819-10-22.
Hepatic resection is the only effective treatment for combined hepatocellular carcinoma and cholangiocarcinoma.
A 52-year-old man was preoperatively diagnosed with hepatocellular carcinoma in segment 2 with tumor thrombus in the segment 2 portal branch. Anatomical liver segmentectomy 2, including separation of the hepatic arteries, portal veins, and bile duct, enabled us to remove the tumor and portal thrombus completely. Modified selective hepatic vascular exclusion, which combines extrahepatic control of the left and middle hepatic veins with occlusion of left hemihepatic inflow, was used to reduce blood loss. A pathological examination revealed combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in the segment 2 portal branch. No postoperative liver failure occurred, and remnant liver function was adequate.
The separation method of the hepatic arteries, portal veins, and bile duct is safe and feasible for a liver cancer patient with portal vein tumor thrombus. Modified selective hepatic vascular exclusion was useful to control bleeding during liver transection. Anatomical liver segmentectomy 2 using these procedures should be considered for a patient with a liver tumor located at segment 2 arising from a damaged liver.
肝切除术是治疗肝细胞癌合并胆管细胞癌的唯一有效方法。
一名 52 岁男性术前诊断为 2 段肝细胞癌,2 段门静脉分支有肿瘤血栓。行解剖性肝 2 段切除术,包括肝动脉、门静脉和胆管的分离,使我们能够完整切除肿瘤和门静脉血栓。改良选择性肝血管阻断术,结合体外控制左、中肝静脉和阻断左半肝入肝血流,可减少出血。病理检查显示 2 段门静脉分支有合并肝细胞癌和胆管细胞癌的肿瘤血栓。术后无肝功能衰竭,残肝功能充足。
对于门静脉癌栓的肝癌患者,肝动脉、门静脉和胆管的分离方法是安全可行的。改良选择性肝血管阻断术有助于控制肝切除时的出血。对于因肝损伤而位于 2 段的肝肿瘤患者,应考虑采用这些方法进行解剖性肝 2 段切除术。